PUBLIC COMPANY
saveUniversity of California Los Angeles
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 8- tagEndocrinology & Metabolism3 co-mentions · 3 sources
- tagAMD2 co-mentions · 2 sources
- tagOncology1 co-mentions · 1 sources
- tagNeurology1 co-mentions · 1 sources
- tagDermatology1 co-mentions · 1 sources
- tagHepatology1 co-mentions · 1 sources
- tagPsychiatry & CNS1 co-mentions · 1 sources
- tagObesity1 co-mentions · 1 sources
pipeline
5
marketed
0
phase 3
0
catalysts ytd
31
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
5Preclinical
Preclinical
Antisense RNAi Oligonucleotide to Inhibit microRNA-214 for Colon Cancer and Ulcerative Colitis
Colon Cancer
PreclinicalGene Therapy to Activate CD40LG for Genetic Disorders
PreclinicalGene Therapy to Target BCMA and CS1 for Multiple Myeloma
Multiple Myeloma (Kahler Disease)
PreclinicalStem Cell Therapy for Ophthalmology
PreclinicalhENPP1mAb
Congestive Heart Failure (Heart Failure)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that